Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Replication protein A2 pseudogene 2 (RPA2P2) is a human pseudogene derived from the parental gene Replication protein A2 (RPA2), which encodes a component of the heterotrimeric replication protein A complex involved in DNA replication, repair, recombination, and the DNA damage response. As a pseudogene, RPA2P2 itself does not encode a functional protein due to mutations or genomic rearrangements that inactivate essential coding or regulatory regions. However, as with many pseudogenes, RPA2P2 may play a regulatory role at the DNA or RNA level, potentially influencing the expression or function of the parental RPA2 gene through sequence exchange, antisense RNA, or acting as a decoy for microRNAs and RNA-binding proteins. There are no reports of RPA2P2 serving as a direct disease biomarker or therapeutic target, but pseudogenes are recognized for their possible involvement in disease mechanisms by modulating the genome or transcriptome, especially in cancer and genomic instability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Replication protein A2 pseudogene 2 (RPA2P2).